Researcher

My Expertise

Emerging infectious diseases, infection, biosecurity, biodefense, biosafety, influenza, vaccines, adult vaccination, elderly vaccination, epidemiology, outbreaks, epidemic control, pandemics, travel and border control, HPV, pneumococcal disease, bioterrorism, smallpox, mpox, anthrax, Ebola, viral haemorrhagic fevers, MERS coronavirus, COVID-19, H5N1, avian influenza, health security, health intelligence, modelling, clinical trials, study design, big data, precision harm, artificial intelligence for epidemic detection.

Fields of Research (FoR)

Infectious Diseases, Epidemiology, Aged Health Care, Public Health and Health Services not elsewhere classified, Genomics, Medical Infection Agents (incl. Prions), Preventive Medicine, Other Artificial Intelligence

SEO tags

Biography

Professor Raina MacIntyre (MBBS Hons 1, FRACP, FAFPHM, M App Epid, PhD) is NHMRC Leadership 3 Fellow and Professor of Global Biosecurity. She heads the Biosecurity Program at the Kirby Institute, which conducts research in epidemiology, bioinformatics, health intelligence, vaccinology, bioterrorism prevention, mathematical modelling, genetic epidemiology, public health and clinical trials in infectious diseases. Her innovation, EPIWATCH®️,...view more

Professor Raina MacIntyre (MBBS Hons 1, FRACP, FAFPHM, M App Epid, PhD) is NHMRC Leadership 3 Fellow and Professor of Global Biosecurity. She heads the Biosecurity Program at the Kirby Institute, which conducts research in epidemiology, bioinformatics, health intelligence, vaccinology, bioterrorism prevention, mathematical modelling, genetic epidemiology, public health and clinical trials in infectious diseases. Her innovation, EPIWATCH®️, which she conceived and developed from 2016 onward is an advanced AI system for real-time global health intelligence. She is an innovator with a talent and vision for advanced health intelligence that can be applied in real-time to solve pressing problems. She has won many awards including the Eureka Prize for Leadership and Innovation in Science in 2022. As of the start of 2024, she is the #1 ranked researcher in the world on Respiratory Protective Devices and highly ranked in Smallpox and several other areas of infectious diseases (Expertscape). Her H index is 78/63 (GS/Scopus) with >28,000 citations. FWCI: 3.69 since 2011, 4.7 since 2020, 30.46  for topic influenza and 18.8 citations per publication in the past 5 years. She has 21.4% of her publications in the top 10% most cited papers (Scopus) in the past 5 years. In 2020 a quote from her invited editorial on masks was featured on the cover of Lancet (Vol 195 June 27 2020), reflecting her global recognition as an expert in masks. Lancet Infectious Diseases published a profile of her in 2021 (VOL 21:4, P468, APRIL 01, 2021).

Her research falls under 4 areas:  Personal protective equipment, Vaccinology, Epidemic response and emerging infectious diseases, and bioterrorism prevention. She is a dual-specialist physician with training in epidemiology and modelling. Her research is underpinned by her clinical training, vaccine program experience, extensive field outbreak investigation and health intelligence/surveillance experience.  She is on the WHO Technical Advisory Group on COVID-19 Vaccine Composition (TAG-CO-VAC 2021-2024), WHO SAGE ad-hoc Working Group on Smallpox and Monkeypox, and is the focal point for WHO GOARN in the UNSW GOARN member group. 

She has led and developed an automated, real-time rapid epidemic intelligence platform, EPIWATCH®️, which uses AI to scan open-source data for early epidemic signals. There are 3 AI systems in EPIWATCH®️ - NLP, a prioritisation algorithm and LLMs. She currently has a Microsoft Accelerating Foundation Models Research Grant to develop advanced AI for EPIWATCH®️ using GPT4. She funds and leads a team of analysts, epidemiologists, LLM/AI specialists and software engineers to further develop EPIWATCH®️ into a global hub of real-time epidemic detection, prevention and mitigation, with a suite of real-time decision support and risk analysis tools. Her vision for EPIWATCH®️ is to be a health intelligence service for global health protection and for public good. A philanthropic gift from Vitalik Buterin’s Balvi Filantropic Fund in 2022-23 has allowed her to expand on EPIWATCH®️ globally in low and middle income countries, making EPIWATCH®️ accessible and equitable. This is called the Shiba Inu EPIWATCH OSINT project and is focused on open-sourcing of EPIWATCH®️. In 2024 she is working with US Indopacific Command on a WarGame, Able Resolve 2024, which features EPIWATCH®️. Innovations that she is researching now include real-time image-based analysis and application of her platform to other intelligence streams. There is vast capability in EPIWATCH®️ to apply her unique vision and talent to much wider applications in defence, biodefense and intelligence. 

Raina has a 31-year track record in pandemics, epidemic infections, serious emerging infections, vaccines and control of respiratory viruses. She has worked as a clinician in hospitals, in health departments on outbreak control, and her PhD research was on screening, surveillance and contact tracing for TB and involved detailed tracking of the risk of infection in high-risk contacts.  She worked for 15 years at the National Centre for Immunisation Research, and has conducted many vaccine clinical trials and has expertise in vaccinology and vaccine programs, especially vaccination of adults, at-risk and immunosuppressed populations.

 She is a graduate of the Australian Field Epidemiology Training program, the MAE at ANU, and has extensive experience in shoe-leather epidemiology of infectious diseases outbreaks. Her in-depth understanding of the science of outbreak investigation draws from this experience combined with her academic training through a Masters and PhD in Epidemiology. She is best known for research in the detailed understanding of the transmission dynamics and prevention of infectious diseases, particularly respiratory pathogens such as influenza, tuberculosis, bioterrorism agents and vaccine-preventable infections. She has led the largest body of research internationally on face masks and respirators in health care workers. Her research has been influential in informing guidelines for health workers on PPE. She has extensive expertise in vaccination programs, with a particular interest in adult vaccination with a focus on the elderly and vaccines for bioterrorism. Specific vaccination interests include influenza, pneumococcal disease, HPV, smallpoxherpes zoster and SARS-CoV2. She has done a body of work on vaccine effectiveness of influenza vaccine against myocardial infarction. She led a NHMRC Centre for Research Excellence in immunisation for high risk populations, a vaccine research centre focused on adult and high-risk group vaccination. Her face mask research has focused on health care workers and hospitals. She does cross-disciplinary research on aerosol dynamics and movement of respiratory droplets, in collaboration with aerospace and fluid mechanics engineers at UNSW, and on development of novel masks and re-usable materials. She currently leads a MRFF-funded study of airborne transmission of SARS-CoV-2 in hospitals, which seeks to develop real-time monitoring and mitigation of air quality and infection risk. She does similar work in aged care facilities.

She has done research on using risk-analysis methods for analysing the origins of emerging infectious diseases outbreaks and is a leader in new approaches to biosecurity through cross-disciplinary response and emerging threats to health security. She is involved in several research studies on COVID-19 and Long COVID. She also designed and co-convened a course, Bioterrorism and Health Intelligence, taken by students at UNSW and ASU.  She has led a smallpox pandemic simulation (Exercise Mataika, 2018 and Pacific Eclipse, 2019) in Australia and the US, which underpinned by modelling research and covers issues such as surveillance, diagnosis, health system capacity, mass quarantine, maritime transport and infected cruise ships, travel bans and the foundations of epidemic control - prescient, as these all came to pass during the COVID-19 pandemic. 

She currently leads a cross-disciplinary NHMRC Centre for Research Excellence, BREATHE, on mitigation of airborne threats to health, which focuses on aged care, healthcare and community settings.  She led a Centre for Research Excellence in Epidemic Response, ISER from 2016-2020She has over 450 publications in peer-reviewed journals. Her passion for field epidemiology led her to co-found the ARM network for Australian outbreak response. She is currently on the Global Accreditation Body for TEPHINET, the network of global field epidemiology programs.

She also has an interest in the ethics of medicine, and specifically in dual-use research of concernhas been on the World Organisation for Animal Health (OIE) committee for developing Guidelines For Responsible Conduct in Veterinary Research Identifying, Assessing and Managing Dual Use Research. She has research collaborations across the PLuS Alliance, with researchers from Arizona State University and Kings College London, and has an adjunct professorships at The College of Public Affairs and Community Solutions and the College of Health Solutions at ASU. She is an adjunct professor at ASU and was among the most highly cited researchers in Arizona during the COVID pandemic. She started a new cross-disciplinary journal, published by UNSW, Global Biosecurity, launched in February 2019. She published her first book, Dark Winter - An insider’s guide to pandemics and biosecurity in 2022, which conveys her knowledge and concerns about biosecurity in lay language for non-expert readers. Her new book, Vaccine Nation - Science, reason and the unravelling of 200 years of progress will be coming out in 2025 (New South Press). She has talent in art (and wanted to be an artist before deciding on medicine as a career) and creative writing, which flows to her creative talent in medical research and ability to apply creativity to complex research problems.  

See Google scholar profile

Interested in Raina's story? Read "First Responder" and Lunch with Raina MacIntyre

Brookings Institute panel 2024: Biosafety and the origin of the COVID-19 pandemic: Evidence and policy implications

 

Zocalo Public Square (JP Getty Museum) panel "Is Civilisation on the Verge of Collapse" - Raina on pandemics in 2019

 

 

Research Highlights:

 

o    She won many career awards including the Sir Henry Wellcome Medal and Prize, from the Association of Military Surgeons of the United States in 2007 for her work on a risk-priority scoring system for category A bioterrorism agents; the Eureka Prize for Leadership and Innovation in Science in 2022 and the highest national award in infectious diseases, the Frank Fenner Award for Research in Infectious Diseases in 2003. She was a finalist in the 2021, 2020 and 2017 Eureka Prizes. In 2021 she received The Women’s Agenda Leadership Award - Frontline Hero and UNSW Medicine  Value in Action Award for Impact. She won the CAPHIA Research Team Prize in 2017, The Public Health Association of Australia National Immunisation Achievement Award in 2014, and also the Peter Baume Public Health Impact Prize in 2014. In 2012 she won the UNSW Medicine Dean's award for outstanding achievement, the highest award in the faculty of Medicine. She has previously held a NHMRC PhD scholarship, a NHMRC Career Development Award, NHMRC Principal Research Fellowship and has been a Harkness Fellow. She spent her Harkness fellowship studying the transmission of tuberculosis in prisons in the US, at Johns Hopkins University.

o    She has published the largest body of clinical trials of face masks in prevention of respiratory infections for health workers internationally, including the only RCT on cloth masks at the time the COVID pandemic began. Her RCTs are cited in policy documents globally, including WHO, CDC, ECDC and others. 

o    She is an expert in health intelligence, outbreak detection and mitigation, including that arising from bioterrorism and biological warfare, with a deep understanding of epidemic control at the population level. She is a leading global expert on smallpox and orthopoxviruses.

o    She initiated and led the creation, funding and training of the Network of Infectious Diseases Modellers of Australia through a NHMRC CBG in Population Health. This is a national network spanning three states and five Universities, which has had a prolific research output. She is interested in applying risk analysis methods to public health.

o    She leads a large program of vaccination clinical research, including studies in frail elderly vaccinology and in immunosuppressed populations such as bone marrow transplant recipients.

Memberships & Professional Activities  

 WHO SAGE Ad Hoc Working Group on Smallpox and Mpox (2022-current)

  • WHO Technical Advisory Group on COVID-19 Vaccine Composition (TAG-CO-VAC) 2021-2024 (member)
  • United States National Academies of Science, Engineering and Medicine Committee on public health interventions and countermeasures for advancing pandemic and seasonal influenza preparedness and response. Member, 2021.
  • Member, NHMRC National COVID-19 Health and Research Advisory Committee 2020-2021
  • Member, NSW Health COVID-19 Vaccine Advisory Group 2020-2021
  • Member, Group of 8 advisory group on social distancing for COVID-19, 2020
  • Member, Global Accreditation Board, TEPHINET 2017-current
  • Member, World Organisation for Animal Health (OIE) Ad Hoc Committee on Guidelines for Managing Dual Use Research 2018.
  • Fellow, Royal Society of NSW (elected 2016)
  • Member, Australian Infection Prevention & Control Ebola Expert Advisory Group - 2014
  • Member, WHO SAGE Committee on Varicella and Zoster Vaccine (2013-2014).
  • Member, US National Academy of Sciences, Institute of Medicine, Committee on Respiratory Protection for Healthcare Workers Against Novel H1N1 Influenza A, 2009.
  • Member of Council, Faculty of Public Health Medicine of Australia (2014-18)
  • Member, Word Organization of Medical Editors (WAME) (2003-current)
  • Member, Australian Society for Infectious Diseases (1998-2013)
  • Member, Public Health Association of Australia - PHAA (current)
  • One Health Special Interest Group committee, PHAA (current)
  • Fellow, Royal Australasian College of Physicians
  • Fellow, Australian Faculty of Public Health Medicine
  • Member, Specialist Influenza Advisory Group to the Chief Medical Officer of Australia, 2007-2010
  • Member, Pandemic Influenza Advisory Group to the Chief Medical Officer of Australia, 2007-2010
  • Member, Association of Military Surgeons of the United States (2007-2009)
  • Member, Infectious Diseases Subgroup of the Detention Health Advisory Group, Australia, 2007-.2008
  • Member, National Health and Medical Research Council (NHMRC) Expert Advisory Group on Antimicrobial Resistance (EAGAR) (2005-2008).
  • Member, Hepatitis B working party of the Ministerial Advisory Committee on AIDS, STDs and Hepatitis.
  • Member, Working Parties for the Australian Technical Advisory Group on Immunisation: Influenza, Hepatitis A; Pneumococcal disease; Varicella zoster; Rotavirus   

Editorial Boards

Epidemiology and Infection

BMJ Open

Vaccine Council of 100

Global Biosecurity

 

 

 

 

 

 

 

 

 

 


My Grants

2023-2027.      NHMRC Investigator grant, L3

2022-2024    MRFF Grant. - Aerosol transmission of SARS-CoV-2 experimentally and in an intensive care setting
2022 - Balvi Filantropic Fund (Vitalik Buterin) gift of $5.39 million for EPIWATCH.

2021-2026 NHMRC Centres for Research Excellence Grant BREATHE - mitigation of airborne threats to health. R MacIntyre, D Heslop, C Doolan, C De Silva, G Marks, H Skouteris

2021-2022 MRFF Frontiers Stage 1 grant - EPIWATCH rapid epidemic intelligence. R MacIntyre, D Heslop, C Paris, S Lim, H Paik, L Yao.

2020-2021 MRFF Research Grants A randomised controlled trial of mask use in control of respiratory outcomes during bushfire season MacIntyre, Shah, Chugtai, Seale

2019-2020 RIS Grant "Volumetric LED-based Flow Diagnostic System" C De Silva, C Doolan, T Barber, D Moreau, M Greeb, M Keevers, CR MacIntyre.

2019-2020 anthrax modelling (Commonwealth of Australia government grant by competitive tender) CR MacIntyre, D Heslop, C Doolan

2018-2023 NHMRC Principal Research Fellowship grant number 1137582

2018-2019 IAMI trial, multicentre RCT. MacIntyre CR (Australian PI) on a trial led by O Frobert in Sweden

2018-2019 Influenza modelling studies. MacIntyre CR (industry grants, Seqirus and Sanofi)

2018 Modelling of smallpox. MacIntyre CR (government grant)

2016 NHMRC Centre for Research Excellence. R MacIntyre, M Kirk, A Clements, P Komesaroff, D Heslop, Q Wang, S Sakar, P Debarro, W Rawlinson, M Baker. Intergrated Systems for Epidemic Response.

2015 NHMRC Project grant. R MacIntyre, L Gardner, A Heywood. “Real time models to inform prevention and control of emerging infectious diseases

2015 NHMRC Project grant. A Newall, R MacIntyre, R Menzies, J Wood, P Beutels. Economic evaluation of alternative pneumococcal vaccination strategies

2012 NHMRC Project Grant #1048180. B Liu, A Newall, R MacIntyre, P McIntyre. Providing the evidence to guide adult immunisation strategies: a novel approach using a large prospective cohort study and record linkage.

2011 NHMRC Centre for Research Excellence in Population Health

Investigators: CR MacIntyre, PB McIntyre, R Booy, N Woods, C Jones, J kaldor, P Beutels, R Menzies, D Dwyer.

Subject: Immunisation in under studied and special risk populations: closing the gap in knowledge through a multidisciplinary approach

 

2011 ARC DP120100189

Investigators: CR MacIntyre, N Zwar, H Worth, A Heywood, H Seale, M Sheikh, M Smith.

Title: "Travellers visiting friends and relatives: new approaches to understanding and reducing infectious disease risks"

 

2009 NHMRC Urgent H1N1 influenza 2009 grant # 630787

Investigators Prof CR MacIntyre; Prof DE Dwyer; Dr H Seale

Subject Efficacy of face masks against H1N1 swine influenza

 

2009-2012 ARC Linkage Grant # LP0990749

Investigators Prof CR MacIntyre; Prof DE Dwyer; A/Prof PT Nga; Prof NM Ferguson; A/Prof M McLaws; Prof L Maher; Dr H Seale; Dr JG Wood; Dr AT Newall

Subject Economic, social and cross cultural issues in non pharmaceutical protection of front line responders to pandemic influenza and emerging infections.

 

2007-2008 ARC Discovery Grant #DP0773987

Investigators CR MacIntyre; AJ Plant; RE Watkins

Subject Who acquires infection from whom across international borders? New approaches for control of emerging infections through understanding travel patterns

 

2006-2009 ARC Linkage Grant #LP0668279

Subject Economic and Social Benefits of treating and preventing influenza in Aged Care Facilities

Investigators R Booy; CR MacIntyre; D Dwyer; RI Lindley

 

2006 NHMRC Strategic Research Grant for Potential Avian Influenza-Induced Pandemic — Urgent Research #373646

Subject Pandemic influenza: developing a model to enhance preparedness in the business sector

Investigators Plant, Aileen; MacIntyre, Raina; Merianos, Angela; Donovan, Robert; Watkins Rochelle.

 

2006 NHMRC Strategic Research Grant for Potential Avian Influenza-Induced Pandemic —Urgent Research #410224

Subject Assessment of interventions for controlling pandemic influenza and determining data needs to inform these assessments

Chief investigators Becker, Niels G; Glass, Kathryn; Mathews, John; Dwyer, Dominic; Nolan, Terrence; MacIntyre, Raina; Barendregt, Jan; Barnes, Belinda; Caley, Peter; McCaw, James; McVernon, Jodie; Philp, David; Wood, James

 

2005-2009 NHMRC Capacity Building Grant in Population Health #358425

Subject Mathematical modeling of infectious diseases

Investigators MacIntyre CR, Becker N, Law M, Plant AJ, Nolan T, Brown GV

 

2005-2008 NHMRC Project grant #352337

Subject Clinical trial of pneumococcal conjugate vaccine in hospitalized geriatric patients.

Investigators MacIntyre CR, Lindley R, McIntyre PB, Sullivan J, Gilbert GL.

 

2005-2008 NHMRC Centre for Clinical Research Excellence #264625

Subject Interdisciplinary clinical and health ethics research and training to improve outcomes in immunosuppressed haematology patients

Investigators Sorrell T, Bradstock K, Kerridge I, Gilbert GL, Gottlieb D, MacIntyre CR, Dwyer D, Ankeny R.

Location Westmead Hospital and NSW Bone Marror Transplant Network

 

2006-2007 Commonwealth Department of Health and Aged Care, Office of Health Protection grant

Subject A Cluster Randomised, Controlled clinical trial of surgical masks and particulate respirators in households for Control of Respiratory Virus Transmission.

Investigators MacIntyre CR, Booy R, Plant AJ, Dwyer D, Wang H, Burgess M, Browne, G, Seale H, Iskander M.


My Qualifications

MBBS (1st Class Honours) University of Sydney 1988

Master of Applied Epidemiology, Australian National University 1992

PhD (Epidemiology) Australian National University 1998

Fellow, Royal Australasian College of Physicians (FRACP) 1994

Fellow, Australian Faculty of Public Health Medicine (FAFPHM) 1995


My Awards

 

2023    Finalist (EPIWATCH) India Australia Business & Community Alliance Awards

2022    Winner (EPIWATCH), AusInnovations Award for Excellence – People's Choice

2022    President’s Award for Excellent Service to The Health of The Nation. Australian Federation of Medical Women.

2022    Eureka Prize for Leadership in Science and Innovation (Department of Defence Prize)

2021    The Women’s Agenda Leadership Award - Frontline Hero
2021    UNSW Medicine  Value in Action Award for Impact

2020, 2021. Finalist, Australian Eureka Prizes

2017 Finalist, Australian Eureka Prizes

2017 CAPHIA Research Team Prize

2016  Elected a Fellow of The NSW Royal Society

2014  Public Health Association of Australia, National Immunisation Achievement Award.

 

2014 Peter Baume Public Health Impact Prize

 

2014 Certificate of Recognition Award to The NHMRC Centre for Research Excellence in immunization from the NSW Refugee Health Service during 2014 Refugee Week, for Highly valued contribution to the promotion of health and wellbeing of refugees and humanitarian entrants.

 

2014

ARM Network shortlisted for Australian Innovations Award

2012                  Deans Award for Outstanding Achievement, UNSW Medicine. This is the highest award made by the Faculty of Medicine in recognition of significant achievements, usually over a prolonged period of time, by academic staff in the areas of education, research and community activity.  This award recognises achievements of the highest standard that give great credit to the individual and to the Faculty.

 

2007                  Sir Henry Wellcome Medal and Prize from the Association of Military Surgeons of the United States of America. Unsolicited award for the following work: MacIntyre CR, Secull A, Lane M, Plant AJ. Development of a risk priority scores for category A bioterrorism agents as an aid for public health policy. Military Medicine. 171(7):589-94, 2006 Jul.

2004                  Robert & Elizabeth Albert Study Grant, Royal Australasian College of Physicians. 

2003                  Frank Fenner Award (Australian Society for Infectious Diseases) for Advanced Research in Infectious Diseases 

2001                  Royal Australasian College of Physicians, Best poster prize, Division of Adult Medicine 

1997                  ASID/ICI (Australian Society for Infectious Diseases) travelling scholarship 

1995                  AEA (Australian Epidemiologic Association) travelling scholarship for outstanding new researchers 

1992                  Australian Faculty of Public Health Medicine (Victoria) – best advanced trainee presentation.

 

Undergraduate Medicine and other Prizes - Sydney University

1984                 A C Stephen Prize for English prose

1985                David Sugerman Prize for Pathology

1985                 Allan Douglas Gillies Memorial Prize for Pathology

1985                 Parkinson Memorial Prize for Pathology

1988                 1st class honours in medicine 

 

1982                Dux (top ranked student in HSC) of Sydney Girl’s High School

1979 & 1980   City of Sydney Eisteddfod medal for debating

1978 & 1979   UNICEF Art awards.


My Research Activities

The Biosecurity Program is focused on global risk analysis, detection, prevention, mitigation, response and control of emerging infectious diseases and bioterrorism. We conduct research on emerging infectious diseases, rapid epidemic surveillance, field response, bioterrorism, bio-intelligence, and health security in a changing biotechnology landscape. We research the rapid detection and prevention of these threats, including open source intelligence and early warnings from EPIWATCH. Our research includes prevention by both pharmaceutical and non-pharmaceutical means such as personal protective equipment and vaccines. The program engages widely with stakeholders from all disciplines involved in large scale epidemic response, such as health, field epidemiology, emergency management, defence, law enforcement, legal and ethics experts.  We are working on several research studies of COVID-19 including transmission, modelling and epidemiology. We are continuing our work on face masks and respirators in prevention of infection. Our Centre for Research Excellence, BREATHE, is doing cross-disciplinary research on airborne threats to health, across aged care, healthcare and community settings. We are also doing cutting-edge research to better understand the global spread of H5N1 avian influenza clade 2.3.4.4b and have a long-standing track record of human and avian influenza research.

The re-emergence of smallpox is a credible threat due to advances in synthetic biology and availability of public methods for synthesis of orthopoxviruses, We are doing modelling research on the control of smallpox through various public health interventions and on re-emergence of monkeypox.


My Research Supervision


Supervision keywords


Areas of supervision

ILP, PhD, Masters

Infectious diseases epidemiology, modelling, clinical research, epidemic infections, vaccines, influenza, COVID-19, avian influenza, emerging infections, risk analysis, biosafety and biosecurity

 


Currently supervising

PhD, ILP, Masters


My Engagement

Brookings Institute panel - Biosafety and the origin of the COVID-19 pandemic: Evidence and policy implications

Could bird flu be the next pandemic?

Bird flu is spreading in alarming new ways - Wired

People Are Worried About Bird Flu — Should They Be?

A person in Texas caught bird flu after mixing with dairy cattle. Should we be worried?

These Arizona scientists had the most impactful COVID research

Portrait of Raina MacIntyre by artist Karen Black, finalist in 2021 Archibald Prize

National Geographic - origins of SARS CoV 2

Science News - cloth masks

2020 - the year that changed us

Fox News - cloths masks should be washed

Nature News - COVID-19 vaccines

BMJ Blogs - cloth face masks should be washed daily

New York Times - are bubble face shields the way of the future?

Time - masks

CNN news - mask research

CBS news - mask research

Time Magazine - facemasks

The Conversation - masks

new York Times - coronavirus

Politico

What is the threat of coronavirus - The Guardian

Has the coronavirus spread to Australia - Radio National

Should i get a face mask (Forbes)

National Public Radio US - face masks

Universal face mask use (Time magazine)

How worried should I be about masks during COVID 19?

Should patients with suspected coronavirus present to their GP?

Stopping the pandemic of coronavirus - opinion piece, SMH

Lunch with Raina MacIntyre

IFL Science

Pacific Eclipse

New research on smallpox - Homeland Security

Smallpox attack could be catastrophic - Homeland Preparedness News

 

Panel discussion at The JP Getty Museum, Los Angeles - Is civilisation on the verge of collapse? Public event in Los Angeles, USA.

 

Are we ready for pandemics (ABC) interview

 

New journal, Global Biosecurity, launched by UNSW

 

Simulated smallpox epidemic reveals global challenges

 

Podcast "Data, disruption and unnatural pandemics". AGSM Activation Event Oct 11 2016

https://soundcloud.com/unswbusiness/agsm-activate-data-disruption

 

Interview on ABC TV on bird flu

 

The falling vaccine rates we don't hear about

 

Social media for disease outbreaks - fad or way of the future?

 

Global biosecurity threats

 

Thinking about getting the flu vaccine? here's what you need to know.

 

Taking the Ouch out of vaccines - the future of needle-free vaccination

 

 Want to boost vaccination? Don't punish the parents

 

How are nurses becoming infected with Ebola?

 

Flu jab may halve heart attack risk

 

Vaccination isn't just for kids - a guide to vaccination for the over 65's

 

Banning unvaccinated kids from childcare may have unofreseen consequences

 

Threats in health security

 

In the news

 

UNSW VIRL


My Teaching

Course convenor and designer 2015-2019: Bioterrorism and Health Intelligence 

Guest lecturer and course designer 2015-2019: Infectious Diseases Intelligence

 

View less

Research Activities

Videos

our UNSW research on face masks
Australian Academy of Science interview on COVID-19
Explainer on SMH
The question of whether civilization is on the verge of collapse may be as old as civilization itself. This enduring query brought together a group of panelists that moderator Edan Lepucki called “the most interesting dinner party I’ve ever been invited to” for a Zócalo/Getty event before an overflow crowd at the Getty Center in Los Angeles. Lepucki, author of the post-apocalyptic novel California, stressed that addressing the event’s title question—”Is Civilization on the Verge of Collapse?”—starts with defining what type of civilization we are talking about.
See full video at: https://www.zocalopublicsquare.org/category/events/video-archive/?postId=103247
An overview of the early assessment of 2019nCoV in China
Raina on the exit strategy for COVID=19
Ebola transmission and occupational risk for health workers
Ebola PPE - respiratory protection
The Fuss about Facemasks
Ebola - 10 min summary of why it matters and what you can do @ UNSW Alliance Against Ebola
Face masks for Infection prevention explained
Elderly vaccine workshop
National Immunisation Award 2014
Immunisation Equity 2017
Epidemiology and infections - talk at the WEHI
launch of Global Security PLuS
Australian Academy of Science
Australian academy of Science interview
Australian Academy of Science
COVID 19 update
Bloomberg Quick takes - mask research
The 2020 Diana Temple Memorial Lecture presented by Raina MacIntyre
Can we eliminate it? The Latest from Science with Prof Raina MacIntyre
What is swine flu?
Is civilisation on the verge of collapse? A Zocalo Public Square event at the JP Getty Museum, Los Angeles.
Interview with BBC World News Jan 21 2020 on 2019nCoV
Q & A with Julia Gillard
The occupational health risk of Ebola for health workers and transmission of infectious disease
Ebola and respiratory protection
The Fuss about Facemasks
UNSW Alliance Against Ebola- Prof. Raina MacIntyre
Facemasks for infection prevention explained
Prof.Raina MacIntyre: 'Elderly Vaccination' presentation
National Immunisation achievement award 2014
Immunisation Equity by 2017: A Golden Age or a Golden Duck - Professor Raina MacIntyre Part I
Raina MacIntyre on Open access science
MacIntyre RC (2012): Science of predicting, preparing, preventing for the next potential pandemic
World Congress of Public Health Pandemic Scenario
Global Security PLUS
No video provider was found to handle the given URL. See the documentation for more information.
The scary Truth about Ebola
Emerging biosecurity threats
Swine flu BBC story
No video provider was found to handle the given URL. See the documentation for more information.
7.30 report on 2019nCoV
ABC news24 interview on 2019nCoV
Al Jazeera News - Raina MacIntyre interviewed on Wuhan coronavirus by Stan Grant
Why do we need to test for COVID-19?
Has the curve flattened?
No video provider was found to handle the given URL. See the documentation for more information.
Can you get reinfected with COVID 19
Kirby seminar
No video provider was found to handle the given URL. See the documentation for more information.
2020 - the year that changed us (7.30 report)